Literature DB >> 16350451

Depolarisation phenomena in traumatic and ischaemic brain injury.

A J Strong1, R Dardis.   

Abstract

1. Cortical spreading depression is a non-physiological global depolarisation of neurones and astrocytes that can be initiated with varying degrees of difficulty in the normally perfused cerebral cortex in the experimental laboratory. Induction is typically with electrical stimulation, needling of the cerebral cortex, or superfusion of isotonic or more concentrated potassium chloride solution. The phenomenon propagates across the cerebral cortex at a rate of 2-5 mm per minute, and is accompanied by marked but transient increases in cerebral blood flow, in local tissue oxygen tension, and most probably in metabolic rate. 2. Peri-infarct depolarisation is also a depolarisation event affecting neurones and glia, with an electrophysiological basis similar or identical to CSD, but occurring spontaneously in the ischaemic penumbra or boundary zone in focal cerebral cortical ischaemia. Most such events arise from the edge of the ischaemic core, and propagate throughout the penumbra, at a rate similar to that of cortical spreading depression. 3. Cortical spreading depression in the normally perfused cortex does not result in histological damage whereas peri-infarct depolarisations augment neuronal damage in the penumbra, and are believed by many authors to constitute an important, or the principal, mechanism by which electrophysiological penumbra progressively deteriorates, ultimately undergoing terminal depolarisation and thus recruitment into an expanded core lesion. 4. There is some experimental evidence to suggest that under some circumstances induction of episodes of cortical spreading depression can confer protection against subsequent ischaemic insults. 5. Although cortical spreading depression and peri-infarct depolarisations have been extensively studied in the experimental in vivo models, there is now clear evidence that depolarisations also occur and propagate in the human brain in areas surrounding a focus of traumatic contusion. 6. Whether such events in the injured human brain represent cortical spreading depression or peri-infarct depolarisation is unclear. However, invasive and probably non-invasive monitoring methods are available which may serve to distinguish which event has occurred. 7. Much further work will be needed to examine the relationship of depolarisation events in the injured brain with outcome from cerebral ischaemia or head injury, to examine the factors which influence the frequency of depolarisation events, and to determine which depolarisation events in the human brain augment the injury and should be prevented.

Entities:  

Mesh:

Year:  2005        PMID: 16350451     DOI: 10.1007/3-211-27208-9_1

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  21 in total

Review 1.  Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology.

Authors:  Vladimir Parpura; Elizabeth S Fisher; James D Lechleiter; Arne Schousboe; Helle S Waagepetersen; Sylvain Brunet; Selva Baltan; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

2.  Astrocyte-neuron interactions in neurological disorders.

Authors:  G Ricci; L Volpi; L Pasquali; L Petrozzi; G Siciliano
Journal:  J Biol Phys       Date:  2009-05-14       Impact factor: 1.365

3.  Neuroprotective Role of Gap Junctions in a Neuron Astrocyte Network Model.

Authors:  Gemma Huguet; Anoushka Joglekar; Leopold Matamba Messi; Richard Buckalew; Sarah Wong; David Terman
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

Review 4.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  A mathematical model of recurrent spreading depolarizations.

Authors:  Cameron Conte; Ray Lee; Monica Sarkar; David Terman
Journal:  J Comput Neurosci       Date:  2017-12-05       Impact factor: 1.621

6.  P2Y1R-initiated, IP3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse.

Authors:  Wei Zheng; Lora Talley Watts; Deborah M Holstein; Jimmy Wewer; James D Lechleiter
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

7.  Acute neuroprotection to pilocarpine-induced seizures is not sustained after traumatic brain injury in the developing rat.

Authors:  G G Gurkoff; C C Giza; D Shin; S Auvin; R Sankar; D A Hovda
Journal:  Neuroscience       Date:  2009-08-18       Impact factor: 3.590

Review 8.  Microdialysis: is it ready for prime time?

Authors:  J Clay Goodman; Claudia S Robertson
Journal:  Curr Opin Crit Care       Date:  2009-04       Impact factor: 3.687

Review 9.  Differences in O2 availability resolve the apparent discrepancies in metabolic intrinsic optical signals in vivo and in vitro.

Authors:  Dennis A Turner; Kelley A Foster; Francesca Galeffi; George G Somjen
Journal:  Trends Neurosci       Date:  2007-06-27       Impact factor: 13.837

10.  Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.

Authors:  Kristian P Doyle; Tao Yang; Nikola S Lessov; Thomas M Ciesielski; Susan L Stevens; Roger P Simon; Jeffrey S King; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-26       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.